+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Treatment; Allergy Type; Distribution Channel, and Geography

  • PDF Icon

    Report

  • 149 Pages
  • July 2020
  • Region: Global
  • The Insight Partners
  • ID: 5136057
UP TO OFF until Mar 31st 2024
Allergy Immunotherapies Market for Sublingual Immunotherapy (SLIT) to Grow at Highest CAGR during 2020-2027.

According to the new market research study on 'Allergy Immunotherapies Market to 2027 - Global Analysis and Forecast - by Application and Distribution Channel,' the market is expected to reach US$ 4,185.89 million by 2027 from US$ 1,819.18 million in 2019. The market is estimated to grow with a CAGR of 11.1% from 2020 to 2027. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth.

Based on treatment, the market is segmented into subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). In 2019, the subcutaneous immunotherapy (SCIT) held the largest share in the market and was forecasted to retain its dominance until 2027. This attributes to be the most efficient and most commonly used form of allergy immunotherapy. The medicine is useful in the treatment of allergic rhinitis, asthma, and stinging insect hypersensitivity. Moreover, SCIT has been productive in the management of more than one type of allergen. Hence, the adoption of SCIT is more than SLIT.

On the other hand, sublingual immunotherapy (SLIT) is expected to witness fastest growth rate owing to factors such as SLIT is anticipated to become a vital alternative for patients who cannot receive allergy shots. It is expected that liquid formulation would also be allowed for therapeutic use in the future. This would augment the increase of the SLIT segment in the forecasted period.

Factors such as growing prevalence of allergic disorders and technological advancements in sublingual dosage formulations. However, the market is likely to get impacted by the drawbacks associated with the use of allergy immunotherapy and regulatory variations across regions during the forecast period.

ALK-Abelló A/S, AIMMUNE THERAPEUTICS, INC., LETIPharma, Stallergenes Greer, HAL Allergy B.V, Anergis, DBV Technologies, Dermapharm Holding Allergy Therapeutics are among the leading companies operating in the allergy immunotherapies market.

The Report Segments Global Allergy Immunotherapies Market as Follows:

By Treatment
  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)

By Allergy Type
  • Allergic Rhinitis
  • Asthma
  • Food Allergy
  • Venom Allergy
  • Others

By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • South and Central America (SCAM)
  • Brazil
  • Argentina

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Allergy Immunotherapies Market - By Treatment
1.3.2 Allergy Immunotherapies Market - By Allergy Type
1.3.3 Allergy Immunotherapies Market - By Distribution Channel
1.3.4 Allergy Immunotherapies Market - By Geography
2. Allergy Immunotherapies Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Allergy Immunotherapies Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia-Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South & Central America - PEST Analysis
4.3 Expert Opinion
5. Allergy immunotherapies Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Prevalence of Allergic Disorders
5.1.2 Technological Advancements in Sublingual Dosage Formulations
5.2 Key Market Restraint
5.2.1 Drawbacks Associated with the Use of Allergy Immunotherapy
5.2.2 Regulatory Variations Across Regions
5.3 Key Market Opportunities
5.3.1 Presence of Strong Product Pipeline
5.4 Future Trends
5.4.1 Increasing FDA Approvals for Drugs
5.5 Impact Analysis
6. Allergy Immunotherapies Market - Global Analysis
6.1 Global Allergy Immunotherapies Market Revenue Forecast And Analysis
6.2 Global Allergy immunotherapies market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Allergy Immunotherapies Market Analysis- by Treatment
7.1 Overview
7.2 Allergy Immunotherapies Market Share, By Treatment, 2019 & 2027 (%)
7.3 Subcutaneous Immunotherapy (SCIT)
7.3.1 Overview
7.3.2 Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
7.4 Sublingual Immunotherapy (SLIT)
7.4.1 Overview
7.4.2 Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
8. Allergy Immunotherapies Market Analysis- by Allergy Type
8.1 Overview
8.2 Allergy Immunotherapies Market Share, By Allergy Type, 2019 & 2027 (%)
8.3 Allergic Rhinitis
8.3.1 Overview
8.3.2 Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
8.4 Asthma
8.4.1 Overview
8.4.2 Asthma Market Revenue and Forecasts to 2027 (US$ Million)
8.5 Food Allergy
8.5.1 Overview
8.5.2 Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.6 Venom Allergy
8.6.1 Overview
8.6.2 Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.7 Other Allergies
8.7.1 Overview
8.7.2 Others Market Revenue and Forecasts to 2027 (US$ Million)
9. Allergy Immunotherapies Market Analysis- by Distribution Channel
9.1 Overview
9.2 Allergy Immunotherapies Market Share, By Distribution Channel, 2019 & 2027 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
10. Allergy Immunotherapies Market Analysis And Forecasts To 2027 - Geographical Analysis
10.1 North America: Allergy immunotherapies market
10.1.1 Overview
10.1.2 North America : Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
10.1.3 North America: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Allergy immunotherapies market, by Country, 2019 & 2027 (%)
10.1.7 US: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1 Europe: Allergy Immunotherapies Market
10.1.1 Overview
10.1.2 Europe: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 Europe: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.1.4 Europe: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.1.5 Europe: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.6 Europe: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
10.1.7 Germany: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Germany: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Germany: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Germany: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Germany: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.8 France: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 France: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 France: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.1.8.3 France: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.4 France: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.9 UK: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 UK: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 UK: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.1.9.3 UK: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.4 UK: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.10 Italy: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.10.1 Italy: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.10.2 Italy: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.1.10.3 Italy: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.1.10.4 Italy: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.1.11 Spain: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Spain: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Spain: Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.1.11.3 Spain: Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.1.11.4 Spain: Allergy Immunotherapies Market, Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2 Asia-Pacific: Allergy Immunotherapies Market
10.2.1 Overview
10.2.2 Asia-Pacific: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Asia-Pacific Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.2.4 Asia-Pacific Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.2.5 Asia-Pacific Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.6 Asia-Pacific: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
10.2.7 China: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.1 China: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Millkion)
10.2.7.2 China Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.2.7.3 China Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.2.7.4 China Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.8 Japan: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.1 Japan: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.2 Japan Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.2.8.3 Japan Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.2.8.4 Japan Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.9 India: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.1 India: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.2 India Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.2.9.3 India Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.2.9.4 India Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.10 South Korea: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.1 South Korea: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.2 South Korea Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.2.10.3 South Korea Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.2.10.4 South Korea Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.2.11 Australia: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Australia: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Australia Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Australia Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.2.11.4 Australia Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3 Middle East & Africa: Allergy immunotherapies market
10.3.1 Overview
10.3.2 Middle East & Africa: Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
10.3.3 Middle East and Africa Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.3.4 Middle East and Africa Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.3.5 Middle East and Africa Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.6 Middle East and Africa: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
10.3.7 Saudi Arabia: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
10.3.7.1 Saudi Arabia: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
10.3.7.2 Saudi Arabia Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.3.7.3 Saudi Arabia Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.3.7.4 Saudi Arabia Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.8 UAE: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
10.3.8.1 UAE: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
10.3.8.2 UAE Allergy Immunotherapies Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.3.8.3 UAE Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.3.8.4 UAE Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.9 South Africa: Allergy immunotherapies market - Revenue and Forecast to 2027 (USD Million)
10.3.9.1 South Africa: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.2 South Africa Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.3.9.3 South Africa Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.3.9.4 South Africa Allergy Immunotherapies Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4 South and Central America: Allergy immunotherapies market
10.4.1 Overview
10.4.2 South and Central America: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.4.3 South and Central America Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.4.4 South and Central America Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.4.5 South and Central America Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4.6 South and Central America: Allergy immunotherapies Market, by Country, 2019 & 2027 (%)
10.4.7 Brazil: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Brazil: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Brazil Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.4.7.3 Brazil Allergy immunotherapies market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.4.7.4 Brazil Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4.8 Argentina: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.1 Argentina: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.2 Argentina Allergy immunotherapies market, by Treatment - Revenue and Forecast to 2027 (USD Million)
10.4.8.3 Argentina Allergy Immunotherapies Market, by Allergy Type - Revenue and Forecast to 2027 (USD Million)
10.4.8.4 Argentina Allergy immunotherapies market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Allergy Immunotherapies Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Allergy Immunotherapies Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 ALK-Abelló A/S
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 AIMMUNE THERAPEUTICS, INC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 LETIPharma
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Stallergenes Greer
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 HAL Allergy B.V.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Johnson and Johnson Services, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Anergis
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 DBV Technologies
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Dermapharm Holding
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Allergy Therapeutics
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of Terms
L

Companies Mentioned

A selection of companies mentioned in this report includes:

  • ALK-Abelló A/S
  • AIMMUNE THERAPEUTICS, INC.
  • LETIPharma
  • Stallergenes Greer
  • HAL Allergy B.V.
  • Johnson and Johnson Services, Inc.
  • Anergis
  • DBV Technologies
  • Dermapharm Holding
  • Allergy Therapeutics